Skip to content

菲利普66

US · PSX #204 按市值排名 上市于 1970
293.17 +3.97 +1.37%
实时 - 追踪5344个代码 - 心跳于152秒前 · 2026-10-16 20:02

✦ 量化股权信号 计算方式说明

增持
  • 最近一期（2026/Q3）披露持股的机构数量增加了3家。
  • 机构持股总比例基本持平。

机构持股

机构持股比例
80.25% -0.02pp
机构数量
2,302 +3
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund59.54%
Hedge Fund8.31%
Public Company7.17%
Government Pension Fund1.67%
Private Company1.38%
Sovereign Wealth Fund1.12%
Family Office/Trust0.40%
Insurance Company0.32%
Bank/Investment Bank0.14%
Other19.97%

主要股东 截至 2026-06-30

BlackRock 8.55% · 34.11M 股
Vanguard Capital Management, LLC 7.13% · 28.44M 股
State Street Global Advisors 6.53% · 26.04M 股
Vanguard Portfolio Management, LLC 5.57% · 22.21M 股
Elliott Management Corporation 4.82% · 19.25M 股
Other 67.41%
Wells Fargo & Company 3.11% · 12.43M 股
Geode Capital Management, LLC 2.79% · 11.12M 股
BNY Mellon Asset Management 1.44% · 5.75M 股
UBS Asset Management 1.19% · 4.76M 股
AQR Capital Management 1.10% · 4.40M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 24次买入 · 25次卖出

姓名职务持股比例
Timothy Roberts Executive Vice President of Midstream & Chemicals 0.02%
Kevin Mitchell Chief Financial Officer 0.02%
Mark Lashier Chief Executive Officer 0.01%
John Lowe Independent Director 0.01%
Brian Mandell Executive Vice President of Marketing & Commercial 0.01%
Glenn Tilton Lead Independent Director 0.01%
Ann Kluppel Vice President 0.01%
Richard Harbison Executive Vice President of Refining 0.01%
Gary Adams Independent Director 0.01%
Sigmund Cornelius Director 0.01%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-15 Brian Mandell Executive Vice President of Marketing & Commercial Derivative Exercise and Sale -23,400 $74.70–265.06
2026-09-09 Ann Kluppel Vice President Other Disposition -40 --
2026-08-11 Richard Harbison Executive Vice President of Refining Derivative Exercise and Sale -52,100 $74.70–223.76
2026-08-10 Brian Mandell Executive Vice President of Marketing & Commercial Derivative Exercise and Sale -33,300 $74.70–215.00
2026-08-09 Lisa Davis Independent Director Open Market Disposition -1,515 $207.21–208.99
2026-08-09 Ann Kluppel Vice President Derivative Exercise and Sale -7,834 $89.05–215.00
2026-07-08 Kevin Mitchell Chief Financial Officer Derivative Exercise and Sale -11,021 $94.97–190.03
2026-05-10 Kevin Mitchell Chief Financial Officer Derivative Exercise and Sale -30,000 $94.85–171.56
2026-05-05 Kevin Meyers Independent Director Open Market Acquisition +175 $173.13
2026-03-31 Donald Baldridge Executive Vice President of Midstream & Chemicals Sale to Issuer -5,885 $177.21
2026-03-29 Kevin Mitchell Chief Financial Officer Derivative Exercise and Sale -15,629 $94.97–190.07
2026-03-16 Kevin Meyers Independent Director Open Market Acquisition +175 $173.20
2026-03-15 Kevin Meyers Independent Director Other Acquisition +949 $172.84
2026-03-15 Howard Ungerleider Independent Director Other Acquisition +949 $172.84
2026-03-12 Lisa Davis Independent Director Open Market Disposition -3,800 $174.37
2026-03-11 Brian Mandell Executive Vice President of Marketing & Commercial Derivative Exercise and Sale -42,800 $89.57–169.53
2026-03-05 Kevin Meyers Independent Director Initial Statement of Beneficial 0 --
2026-03-04 Kevin Mitchell Chief Financial Officer Derivative Exercise and Sale -21,800 $94.85–168.22
2026-02-16 Donald Baldridge Executive Vice President of Midstream & Chemicals Open Market Disposition -7,500 $160.00
2026-02-09 Mark Lashier Chief Executive Officer Other Acquisition +29,148 $156.70

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:20 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

菲利普66 讨论区 0 条评论

发表评论